CULLINAN THERAPEUTICS, INC. Depreciation and Amortization
CULLINAN THERAPEUTICS, INC. (CGEM) reported Depreciation and Amortization of $158.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DepreciationDepletionAndAmortization · last filed 2026-08-06
- CULLINAN THERAPEUTICS, INC. depreciation, depletion and amortization for the quarter ending 2026-06-30 was $79.00K, a 2.60% increase year-over-year.
- CULLINAN THERAPEUTICS, INC. depreciation, depletion and amortization for the quarter ending 2026-03-31 was $79.00K, a 3.95% increase year-over-year.
- CULLINAN THERAPEUTICS, INC. depreciation, depletion and amortization for the quarter ending 2025-12-31 was $79.00K, a 2.60% increase year-over-year.
- CULLINAN THERAPEUTICS, INC. depreciation, depletion and amortization for the quarter ending 2025-09-30 was $79.00K, a 3.95% increase year-over-year.
- CULLINAN THERAPEUTICS, INC. depreciation, depletion and amortization for fiscal 2025 was $311.00K, a 1.63% increase from fiscal 2024.
- CULLINAN THERAPEUTICS, INC. depreciation, depletion and amortization for fiscal 2024 was $306.00K, a 1.29% decline from fiscal 2023.
- CULLINAN THERAPEUTICS, INC. depreciation, depletion and amortization for fiscal 2023 was $310.00K, a 233.33% increase from fiscal 2022.
- CULLINAN THERAPEUTICS, INC. depreciation, depletion and amortization for fiscal 2022 was $93.00K, a 75.47% increase from fiscal 2021.
| Period end | Depreciation, Depletion and Amortization 3 month | Depreciation, Depletion and Amortization 6 month | Depreciation, Depletion and Amortization 9 month | Depreciation, Depletion and Amortization 12 month |
|---|---|---|---|---|
| 2026-06-30 | $79.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $158.00K 10-Q · filed 2026-08-06 | $237.00K derived: sum of 3 quarters · filed 2026-08-06 | $316.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $79.00K 10-Q · filed 2026-05-07 | $158.00K derived: sum of 2 quarters · filed 2026-05-07 | $237.00K derived: sum of 3 quarters · filed 2026-05-07 | $314.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $79.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $158.00K derived: sum of 2 quarters · filed 2026-03-10 | $235.00K derived: sum of 3 quarters · filed 2026-08-06 | $311.00K 10-K · filed 2026-03-10 |
| 2025-09-30 | $79.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $156.00K derived: sum of 2 quarters · filed 2026-08-06 | $232.00K 10-Q · filed 2025-11-06 | $309.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $77.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $153.00K 10-Q · filed 2026-08-06 | $230.00K derived: sum of 3 quarters · filed 2026-08-06 | $306.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $76.00K 10-Q · filed 2026-05-07 | $153.00K derived: sum of 2 quarters · filed 2026-05-07 | $229.00K derived: sum of 3 quarters · filed 2026-05-07 | $306.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $153.00K derived: sum of 2 quarters · filed 2026-03-10 | $230.00K derived: sum of 3 quarters · filed 2026-03-10 | $306.00K 10-K · filed 2026-03-10 |
| 2024-09-30 | $76.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $153.00K derived: sum of 2 quarters · filed 2025-11-06 | $229.00K 10-Q · filed 2025-11-06 | $306.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $77.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $153.00K 10-Q · filed 2025-08-07 | $230.00K derived: sum of 3 quarters · filed 2025-08-07 | $310.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $76.00K 10-Q · filed 2025-05-08 | $153.00K derived: sum of 2 quarters · filed 2025-05-08 | $233.00K derived: sum of 3 quarters · filed 2025-05-08 | $314.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $157.00K derived: sum of 2 quarters · filed 2025-02-27 | $238.00K derived: sum of 3 quarters · filed 2025-02-27 | $310.00K 10-K · filed 2025-02-27 |
| 2023-09-30 | $80.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $161.00K derived: sum of 2 quarters · filed 2024-11-07 | $233.00K 10-Q · filed 2024-11-07 | $292.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $81.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $153.00K 10-Q · filed 2024-08-08 | $212.00K derived: sum of 3 quarters · filed 2024-08-08 | $221.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $72.00K 10-Q · filed 2024-05-15 | $131.00K derived: sum of 2 quarters · filed 2024-05-15 | $140.00K derived: sum of 3 quarters · filed 2024-05-15 | $152.00K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $68.00K derived: sum of 2 quarters · filed 2024-03-14 | $80.00K derived: sum of 3 quarters · filed 2024-03-14 | $93.00K 10-K · filed 2024-03-14 |
| 2022-09-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $21.00K derived: sum of 2 quarters · filed 2023-11-08 | $34.00K 10-Q · filed 2023-11-08 | $46.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $25.00K 10-Q · filed 2023-08-10 | $37.00K derived: sum of 3 quarters · filed 2023-08-10 | $50.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $13.00K 10-Q · filed 2023-05-11 | $25.00K derived: sum of 2 quarters · filed 2023-05-11 | $38.00K derived: sum of 3 quarters · filed 2023-05-11 | $51.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $25.00K derived: sum of 2 quarters · filed 2023-03-09 | $38.00K derived: sum of 3 quarters · filed 2023-03-09 | $53.00K 10-K · filed 2023-03-09 |
| 2021-09-30 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $26.00K derived: sum of 2 quarters · filed 2022-11-14 | $41.00K 10-Q · filed 2022-11-14 | $56.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $28.00K 10-Q · filed 2022-08-10 | $43.00K derived: sum of 3 quarters · filed 2022-08-10 | $58.00K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $15.00K 10-Q · filed 2022-05-16 | $30.00K derived: sum of 2 quarters · filed 2022-05-16 | $45.00K derived: sum of 3 quarters · filed 2022-05-16 | $61.00K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $30.00K derived: sum of 2 quarters · filed 2022-03-17 | $46.00K derived: sum of 3 quarters · filed 2022-03-17 | $62.00K 10-K · filed 2022-03-17 |
| 2020-09-30 | $15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $31.00K derived: sum of 2 quarters · filed 2021-11-09 | $47.00K 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $32.00K 10-Q · filed 2021-08-10 | ||
| 2020-03-31 | $16.00K 10-Q · filed 2021-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |